Organogenesis Holdings (ORGO) EBITDA Margin Growth (1y) (2018 - 2026)
Organogenesis Holdings (ORGO) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 241.91 Mn | 195.06 Mn | 20.08 Mn | -10,409.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,409.00 |
| Mar 31, 2026 | -15,420.00 |
| Dec 31, 2025 | 1,998.00 |
| Sep 30, 2025 | 832.00 |
| Jun 30, 2025 | -178.00 |
| Mar 31, 2025 | -2,735.00 |
| Dec 31, 2024 | 934.00 |
| Sep 30, 2024 | -200.00 |
| Jun 30, 2024 | -1,897.00 |
| Mar 31, 2024 | 21.00 |
| Dec 31, 2023 | -882.00 |
| Sep 30, 2023 | 589.00 |
| Jun 30, 2023 | -152.00 |
| Mar 31, 2023 | -359.00 |
| Dec 31, 2022 | -790.00 |
| Sep 30, 2022 | -1,278.00 |
| Jun 30, 2022 | -931.00 |
| Mar 31, 2022 | -1,243.00 |
| Dec 31, 2021 | -477.00 |
| Sep 30, 2021 | -832.00 |